"Platelet-Rich Fibrin Membrane-as a Novel Biomaterial for Pressure Injury Healing in a Person with Spinal Cord Injury: A Case Report"

Overview

Journal Spinal Cord Ser Cases

Specialty Neurology

Date 2022 Aug 10

PMID 35948536

Authors

Raktim Swarnakar

Hafis Rahman

Srikumar Venkataraman

Affiliations

Soon will be listed here.

Abstract

Introduction: Pressure injury (PI) impacts the quality of life, and socioeconomic and psychological well-being negatively in persons with Spinal Cord Injury (SCI). Autologous Platelet Rich Plasma (PRP) and Platelet Rich Fibrin (PRF) showed promising roles in wound healing. PRF is considered a second-generation PRP, contains more growth factors and is more biocompatible than PRP. It possesses an additional favourable impact on wound healing due to its three-dimensional fibrin architecture, and antimicrobial property. There are no studies on PRF membrane use for PI healing in SCI.

Case Presentation: A 25-year-old male with operated traumatic T10 American Spinal Injury Association Impairment Scale grade A paraplegia with neurogenic bowel, and bladder and a stage II PI over the left greater trochanter, was admitted for inpatient rehabilitation. The chronic non-healing PI which did not show any improvement following normal saline (0.9%) dressing for the past 3 months, was treated with autologous PRF membrane weekly for four weeks. The PI healed completely and no adverse events were noted. Weekly total scores of the Spinal Cord Impairment Pressure Ulcer Monitoring Tool and Pressure Ulcer Scale for Healing were 6, 6, 5, 2, 0 and 12, 10, 10, 3, and 0 respectively.

Discussion: To the best of our knowledge, this is the first case report on the healing of PI in SCI with the use of PRF. This novel biomaterial is a safe and effective promising agent for PI management in SCI. But further randomized trials are needed to establish stronger evidence regarding feasibility and effectiveness.

Citing Articles

Focuses and Trends of Research on Platelet-Rich Fibrin: A Bibliometric and Visual Analysis.

Zhao Y, Dong C, Fan L, Lei T, Ge X, Yu Z Indian J Plast Surg. 2024; 57(5):356-363.

PMID: 39552803 PMC: 11567770. DOI: 10.1055/s-0044-1779478.

L-PRF in extra-oral wound care.

Pinto N, Yu J, Koirala S, Mourao C, Andrade C, Rescigno E Periodontol 2000. 2024; 97(1):342-362.

PMID: 39305000 PMC: 11808448. DOI: 10.1111/prd.12605.

Role of Autologous Platelet-Rich Fibrin in Chronic Non-healing Ulcers With Various Etiologies in a Tertiary Care Rehabilitation Centre: A Case Series.

Sharma A, Kaur A, Asthana S, Nongrum I, Rai S, Sunaina K Cureus. 2024; 16(9):e68709.

PMID: 39238924 PMC: 11376230. DOI: 10.7759/cureus.68709.

Descriptive Analysis of Surgical Outcomes and Stoma Formation for Treating Sacral and Anal Pressure Injuries in Spinal Cord Injury: A Retrospective Study of Selected Cases.

Heller R, Torri M, Gaab J, Haubruck P, Moghaddam-Alvandi A, Biglari B SAGE Open Nurs. 2024; 10:23779608241229507.

PMID: 38379575 PMC: 10878226. DOI: 10.1177/23779608241229507.

References

Dorner B, Posthauer M, Thomas D . The role of nutrition in pressure ulcer prevention and treatment: National Pressure Ulcer Advisory Panel white paper. Adv Skin Wound Care. 2009; 22(5):212-21. DOI: 10.1097/01.ASW.0000350838.11854.0a. View

Shiferaw W, Akalu T, Mulugeta H, Aynalem Y . The global burden of pressure ulcers among patients with spinal cord injury: a systematic review and meta-analysis. BMC Musculoskelet Disord. 2020; 21(1):334. PMC: 7260823. DOI: 10.1186/s12891-020-03369-0. View

Chen J, Wan Y, Lin Y, Jiang H . Platelet-rich fibrin and concentrated growth factors as novel platelet concentrates for chronic hard-to-heal skin ulcers: a systematic review and Meta-analysis of randomized controlled trials. J Dermatolog Treat. 2020; 33(2):613-621. DOI: 10.1080/09546634.2020.1773386. View

Stotts N, Rodeheaver G, Thomas D, Frantz R, Bartolucci A, Sussman C . An instrument to measure healing in pressure ulcers: development and validation of the pressure ulcer scale for healing (PUSH). J Gerontol A Biol Sci Med Sci. 2001; 56(12):M795-9. DOI: 10.1093/gerona/56.12.m795. View

Dana A, Bauman W . Bacteriology of pressure ulcers in individuals with spinal cord injury: What we know and what we should know. J Spinal Cord Med. 2014; 38(2):147-60. PMC: 4397196. DOI: 10.1179/2045772314Y.0000000234. View

Miron R, Fujioka-Kobayashi M, Bishara M, Zhang Y, Hernandez M, Choukroun J . Platelet-Rich Fibrin and Soft Tissue Wound Healing: A Systematic Review. Tissue Eng Part B Rev. 2016; 23(1):83-99. DOI: 10.1089/ten.TEB.2016.0233. View

Adriaansen J, Ruijs L, van Koppenhagen C, van Asbeck F, Snoek G, van Kuppevelt D . Secondary health conditions and quality of life in persons living with spinal cord injury for at least ten years. J Rehabil Med. 2016; 48(10):853-860. DOI: 10.2340/16501977-2166. View

Adamson R . Role of macrophages in normal wound healing: an overview. J Wound Care. 2009; 18(8):349-51. DOI: 10.12968/jowc.2009.18.8.43636. View

Bensaid W, Triffitt J, Blanchat C, Oudina K, Sedel L, Petite H . A biodegradable fibrin scaffold for mesenchymal stem cell transplantation. Biomaterials. 2003; 24(14):2497-502. DOI: 10.1016/s0142-9612(02)00618-x. View

10.

Martinez-Zapata M, Marti-Carvajal A, Sola I, Exposito J, Bolibar I, Rodriguez L . Autologous platelet-rich plasma for treating chronic wounds. Cochrane Database Syst Rev. 2016; (5):CD006899. PMC: 9308064. DOI: 10.1002/14651858.CD006899.pub3. View

11.

Jorgensen B, Karlsmark T, Vogensen H, Haase L, Lundquist R . A pilot study to evaluate the safety and clinical performance of Leucopatch, an autologous, additive-free, platelet-rich fibrin for the treatment of recalcitrant chronic wounds. Int J Low Extrem Wounds. 2011; 10(4):218-23. DOI: 10.1177/1534734611426755. View

12.

Choukroun J, Diss A, Simonpieri A, Girard M, Schoeffler C, Dohan S . Platelet-rich fibrin (PRF): a second-generation platelet concentrate. Part IV: clinical effects on tissue healing. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006; 101(3):e56-60. DOI: 10.1016/j.tripleo.2005.07.011. View

13.

Nagaraju U, Sundar P, Agarwal P, Raju B, Kumar M . Autologous Platelet-rich Fibrin Matrix in Non-healing Trophic Ulcers in Patients with Hansen's Disease. J Cutan Aesthet Surg. 2017; 10(1):3-7. PMC: 5418979. DOI: 10.4103/JCAS.JCAS_17_16. View

14.

Dohan Ehrenfest D, Del Corso M, Diss A, Mouhyi J, Charrier J . Three-dimensional architecture and cell composition of a Choukroun's platelet-rich fibrin clot and membrane. J Periodontol. 2010; 81(4):546-55. DOI: 10.1902/jop.2009.090531. View

15.

Singh R, Rohilla R, Dhayal R, Sen R, Sehgal P . Role of local application of autologous platelet-rich plasma in the management of pressure ulcers in spinal cord injury patients. Spinal Cord. 2014; 52(11):809-16. DOI: 10.1038/sc.2014.144. View

16.

Dohan Ehrenfest D, Bielecki T, Jimbo R, Barbe G, Del Corso M, Inchingolo F . Do the fibrin architecture and leukocyte content influence the growth factor release of platelet concentrates? An evidence-based answer comparing a pure platelet-rich plasma (P-PRP) gel and a leukocyte- and platelet-rich fibrin (L-PRF). Curr Pharm Biotechnol. 2011; 13(7):1145-52. DOI: 10.2174/138920112800624382. View

17.

Scevola S, Nicoletti G, Brenta F, Isernia P, Maestri M, Faga A . Allogenic platelet gel in the treatment of pressure sores: a pilot study. Int Wound J. 2010; 7(3):184-90. PMC: 7951528. DOI: 10.1111/j.1742-481X.2010.00671.x. View

18.

Dohan D, Choukroun J, Diss A, Dohan S, Dohan A, Mouhyi J . Platelet-rich fibrin (PRF): a second-generation platelet concentrate. Part III: leucocyte activation: a new feature for platelet concentrates?. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006; 101(3):e51-5. DOI: 10.1016/j.tripleo.2005.07.010. View

19.

Byrne D, Salzberg C . Major risk factors for pressure ulcers in the spinal cord disabled: a literature review. Spinal Cord. 1996; 34(5):255-63. DOI: 10.1038/sc.1996.46. View

20.

Strauss F, Nasirzade J, Kargarpoor Z, Stahli A, Gruber R . Effect of platelet-rich fibrin on cell proliferation, migration, differentiation, inflammation, and osteoclastogenesis: a systematic review of in vitro studies. Clin Oral Investig. 2019; 24(2):569-584. PMC: 6988133. DOI: 10.1007/s00784-019-03156-9. View